Cargando…
A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome
OBJECTIVE: Patients often develop neuropsychiatric symptoms such as anxiety and agitation after they have started taking an antidepressant, and this is thought to be associated with a potentially increased risk of suicide. However, the incidence of antidepressant-induced jitteriness/anxiety syndrome...
Autores principales: | Harada, Tsuyoto, Inada, Ken, Yamada, Kazuo, Sakamoto, Kaoru, Ishigooka, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235204/ https://www.ncbi.nlm.nih.gov/pubmed/25419134 http://dx.doi.org/10.2147/NDT.S70637 |
Ejemplares similares
-
A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression
por: Sugawara, Hiroko, et al.
Publicado: (2016) -
Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline
por: Nakamura, Toshinori, et al.
Publicado: (2017) -
Too Jittery to Sleep? Temporal Associations of Actigraphic Sleep and Caffeine in Adolescents
por: Mathew, Gina Marie, et al.
Publicado: (2021) -
Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX‐2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis
por: Shirata, Toshinori, et al.
Publicado: (2023) -
Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
por: Bonnet, Udo
Publicado: (2023)